Results 181 to 190 of about 19,745 (243)

BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma

Pigment Cell &Melanoma Research, Volume 38, Issue 3, May 2025.
ABSTRACT Uveal melanoma (UM) is an aggressive intraocular malignancy. Despite effective control of primary tumors, ~50% of UM patients develop metastases, with the liver being the predominant secondary site. BAP1 deficiency, present in ~80% of metastatic UM cases, is strongly associated with increased metastatic risk and poor prognosis.
C. J. Cunanan, A. Amirfallah, A. B. Sanders, K. C. Gallant, M. R. Cavallo, E. A. Homer, O. S. El Naggar, J. K. Farnan, G. Romano, J. L. Hope, J. G. Jackson, E. J. Hartsough   +11 more
wiley   +1 more source

Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer. [PDF]

J Immunother Cancer
Sun Y, Zhou L, Gu X, Zhao J, Bi J, Pan L.   +5 more
europepmc   +1 more source

Immunotherapy targeting a leader sequence cathepsin G-derived peptide. [PDF]

Leukemia
Shi C, Tian Z, Yan J, Zhang M, Sukhumalchandra P, Chang E, Yang G, You J, Cui M, Shi Q, Kerros C, Philips A, Qiao N, Torikai H, Patchametla S, Sergeeva A, St John L, He H, Wiederschain D, Lee BH, Paulus GLC, Zha D, Molldrem J, Alatrash G.   +23 more
europepmc   +1 more source

Novelties on Multiple Myeloma from the Main 2024 Hematology Conferences. [PDF]

Mediterr J Hematol Infect Dis
Morè S, Corvatta L, Manieri VM, Morsia E, Poloni A, Offidani M.   +5 more
europepmc   +1 more source

Advances in Antibody-Based Immune-Stimulating Drugs: Driving Innovation in Cancer Therapy. [PDF]

Int J Mol Sci
Zhao RJ, Fan XX.
europepmc   +1 more source

Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers. [PDF]

Mol Ther Nucleic Acids
Dietmair B, Humphries J, Mercer TR, Thurecht KJ, Howard CB, Cheetham SW.   +5 more
europepmc   +1 more source

Understanding IgM Structure and Biology to Engineer New Antibody Therapeutics. [PDF]

BioDrugs
Buchner J, Sitia R, Svilenov HL.
europepmc   +1 more source

Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV. [PDF]

Viruses
Zhao C, Hao M, Bian T, Zhao X, Chi X, Chen Z, Fu G, Zhu Z, Fang T, Yu C, Li J, Chen W.   +11 more
europepmc   +1 more source

Correction for Ramos et al., "Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase". [PDF]

mBio
Ramos KE, Okba NMA, Tan J, Bandawane P, Meade P, Loganathan M, Francis B, Shulenin S, Holtsberg FW, Aman MJ, McMahon M, Krammer F, Lai JR.   +12 more
europepmc   +1 more source

Characteristics of second primary malignancies following bispecific antibodies therapy. [PDF]

J Immunother Cancer
Liang X, Luo B, Lin B, Liu D, Guo J, Lu W, Tian S, Cai Z, Zhou X, Jin Z, Li T, Chen K, Zhou H, Wang L.   +13 more
europepmc   +1 more source